by Gary Chandler | Nov 5, 2019 | Alzheimer's Disease Treatment
Drug Targets Brain And Microbiome China has granted conditional approval to an Alzheimer’s disease drug that is derived from seaweed, potentially shaking up the field after years of clinical failures involving experimental therapies from major drug...
by Gary Chandler | Jun 14, 2017 | Alzheimer's Disease Prevention
Hope Against Neurodegenerative Disease Alzheimer’s disease drug treatments have met failure after failure. Many people have decided that prevention is the only hope. Unfortunately, a U.S. panel of experts claims that prevention might be just as elusive as a cure....
by Gary Chandler | May 31, 2014 | Alzheimer's Disease Research
Prion Pioneer Prusiner Leads Research Daiichi Sankyo Co. Ltd. and University of California, San Francisco (UCSF) announced that they have established a drug discovery collaboration focused on developing novel therapeutics and molecular diagnostics for multiple...
by Gary Chandler | Jan 6, 2010 | Alzheimer's Disease Treatment
Caregivers Overwhelmed By Alzheimer’s Disease We know a lot about Alzheimer’s disease. For example, we know that it is the sixth-leading cause of death in the United States. We know that one in three seniors dies with some form of dementia. And we know...
